Literature DB >> 23909822

Episodic ataxia type 1 without episodic ataxia: the diagnostic utility of nerve excitability studies in individuals with KCNA1 mutations.

S Veronica Tan1, Elizabeth Wraige, Karine Lascelles, Hugh Bostock.   

Abstract

Episodic ataxia type 1 (EA1) is caused by mutations in the KCNA1 gene encoding the fast potassium channel Kv1.1 and is characterized clinically by brief episodes of ataxia and continuous and spontaneous motor unit activity. Atypical presentations, in which the predominant manifestation is related to the peripheral nervous system, may lead to the diagnosis being missed or delayed, with the potential risk of individuals receiving inappropriate or unnecessary investigations and treatment. We present a case of a 15-year-old female with EA1 who had never had episodes of ataxia, and whose hand movements were initially thought to represent a tremor. Genetic screening for KCNA1 mutations was precipitated by the results of the nerve excitability studies (TROND protocol), which showed changes typical of reduced fast potassium channel conductance. This case highlights the utility of nerve excitability studies in identifying individuals with KCNA1 mutations.
© 2013 Mac Keith Press.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23909822     DOI: 10.1111/dmcn.12236

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  7 in total

1.  Clinical heterogeneity associated with KCNA1 mutations include cataplexy and nonataxic presentations.

Authors:  Catherine A Brownstein; Alan H Beggs; Lance Rodan; Jiahai Shi; Meghan C Towne; Renee Pelletier; Siqi Cao; Paul A Rosenberg; David K Urion; Jonathan Picker; Wen-Hann Tan; Pankaj B Agrawal
Journal:  Neurogenetics       Date:  2015-09-22       Impact factor: 2.660

Review 2.  The Clinical Spectrum of Autosomal-Dominant Episodic Ataxias.

Authors:  Stefan Kipfer; Michael Strupp
Journal:  Mov Disord Clin Pract       Date:  2014-07-28

3.  Whole-exome sequencing as a diagnostic tool in a family with episodic ataxia type 1.

Authors:  Pawel Tacik; Kimberly J Guthrie; Audrey J Strongosky; Daniel F Broderick; Douglas L Riegert-Johnson; Sha Tang; Dima El-Khechen; Alexander S Parker; Owen A Ross; Zbigniew K Wszolek
Journal:  Mayo Clin Proc       Date:  2015-02-03       Impact factor: 7.616

4.  Mutations in the sodium channel gene SCN2A cause neonatal epilepsy with late-onset episodic ataxia.

Authors:  N Schwarz; A Hahn; T Bast; S Müller; H Löffler; S Maljevic; E Gaily; I Prehl; S Biskup; T Joensuu; A-E Lehesjoki; B A Neubauer; H Lerche; U B S Hedrich
Journal:  J Neurol       Date:  2015-12-08       Impact factor: 4.849

Review 5.  Clinical and Genetic Overview of Paroxysmal Movement Disorders and Episodic Ataxias.

Authors:  Giacomo Garone; Alessandro Capuano; Lorena Travaglini; Federica Graziola; Fabrizia Stregapede; Ginevra Zanni; Federico Vigevano; Enrico Bertini; Francesco Nicita
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

6.  Case report: A novel loss-of-function pathogenic variant in the KCNA1 cytoplasmic N-terminus causing carbamazepine-responsive type 1 episodic ataxia.

Authors:  Rían W Manville; Richard Sidlow; Geoffrey W Abbott
Journal:  Front Neurol       Date:  2022-08-09       Impact factor: 4.086

7.  Peripheral nerve axonal excitability studies: expanding the neurophysiologist's armamentarium.

Authors:  William Huynh; Matthew C Kiernan
Journal:  Cerebellum Ataxias       Date:  2015-03-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.